A novel compound JPM8: In vivo penile activity promotion in rats, effect on the relaxation and cGMP/cAMP accumulation in isolated rabbit corpora cavernosa

International Journal of Impotence Research

Volumn 14, Issue 6, 2002, Pages 453-461

  El Thaher, T S ^a   Khatib, S ^b   Saleem, M ^a   Shnoudeh, A ^c   Badwan, A A ^a,d  

^a JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d NONE   (Jordan)

Author keywords

cGMP; Erectile dysfunction; Inhibitors; JPM8; Phosphodiesterase type 5 (PDE 5); Sildenafil

Indexed keywords

CYCLIC AMP; CYCLIC GMP; JPM 8; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DISEASE MODEL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH PROMOTION; INCUBATION TIME; MALE; NONHUMAN; PENIS INJURY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RABBIT; RAT; SEXUAL BEHAVIOR;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ADMINISTRATION, ORAL; ANIMALS; CYCLIC AMP; CYCLIC GMP; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; PENILE ERECTION; PENIS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PIPERAZINES; RABBITS; RATS; RATS, WISTAR;

EID: 0036941968     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900908     Document Type: Article

References (30)

1. Wagner G, Saenz de Tejada I. Clinical review. Update on male erectile dysfunction. Br Med J 1998; 316: 678-682.
2. Burnett AL. Role of nitric oxide in the physiology of erection. Biol Reprod 1995; 52: 485-489.
3. Meinhardt W, Kropman RF, Vermeji P. Comparative tolerability and efficacy of treatments of impotence. Drug Safety 1999; 20: 133-146.
4. Terrett NK, Bell AS, Brown D, Ellis P. Sildenafil (Viagra®), a potent and selective inhibitor of type 5-cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorg Med Chem Lett 1996; 6: 1819-1824.
5. Takase Y, Saeki T, Fujimoto M, Saito I. Cyclic GMP phosphodiesterease inhibitors. 1: The discovery of a novel inhibitor, 4-((3,4-(methylenedioxy)benzyl)amino)-6,7,8- trimethoxy-quinazoline. J Med Chem 1993; 36: 3765-3770.
6. Watanabe N et al. 4-(3-chloro-4-methoxybenzyl)aminophthalazines: synthesis and inhibitory activity towards phosphodiesterase 5. Chem J Med 2000; 43: 2523-2529.
7. Daugan A. Tricyclic derivatives, process and use. Patent WO9519978, 1995.
8. Oku T et al. Indole derivatives as cGMP-PDE inhibitors. Patent WO9632379, 1996.
9. Notsu, T, Ohzawa N, Nakai Y. Therapeutic agent for erection failure. Patent WO9853819, 1998.
10. Kim DK et al. Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues. Bioorg Med Chem 2001; 9: 1609-1616.
11. Burnett AL. General use of animal models for the investigation of the physiology of erection. Int J Impot Res 2001; 13: 135-139.
12. Quinlan DM et al. The rat as a model for the study of penile erection. J Urol 1989; 141: 656-661.
13. Martinez-Pineiro L et al. Rat model for the study of penile erection: pharmacologic and electrical stimulation parameters. Eur Uro 1994; 25: 62-70.
14. Saenz Tejada I et al. Trabecular smooth muscle modulates the capacitor function of the penis. Studies on rabbit model. Am J Physiol 1991; 260: H1590-H1595.
15. Badwan AA, El-Abadelah MM. Compounds and pharmaceutical compositions containing the same. Patent EP 1057829 A1 (2000); patent US 6242444 B1 (2001); and patent P3145364 (2001).
16. El-Thaher TS, Matalka KZ, Taha HA, Badwan AA. Ferula harmonis 'Zallouh' and enhancing erectile function in rats: efficacy and toxicity study. Int J Impot Res 2001; 13: 247-251.
17. Ang HH, Sim MK. Effects of Eurycoma longifolia jack on penile erection index and homosexual mounting in rats. Pharm Sci 1997; 3: 117-119.
18. Ballard SA et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isoenzymes. J Urol 1998; 159: 2164-2171.
19. Argiolas A, Melis MR, Gessa GL. Yawning and penile erection: central copamine-oxytocin-adrenocorticotropin connection. Ann NY Acad Sci 1988; 525: 330-337.
20. Maeda N et al. A screening concept based on a hypothesis led to the development of putative cognitive enhancer the stimulates penile erection. Jpn J Pharmacol 1994; 64: 147-153.
21. Chuang AT, Strauss JD, Murphy RA, Steers WD. Sildenafil, a type-5 cGMP phosphodiesterases inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 1998; 160: 257-261.
22. Qiu Y, Kraft P, Lombardi E, Clancy J. Rabbit corpus cavernosum smooth muscle shows a different phosphdiesterase profile than human corpus cavernosum. J Urol 2000; 164: 882-886.
23. Gocmen C, Ucar P, Singirik E, Dikmen A. An in vitro study of nonadrenergic-noncholinergic activity on the cavernous tissue of mouse. Urol Res 1997; 25: 269-275.
24. Cartledge JJ, Minhas S, Eardley, Morrison JFB. Endothelial and neuronal-derived nitric oxide mediated relaxation of corpus cavernosal smooth muscle in rat, in vitro, model of erectile dynsfunction. Int J Impot Res 2000; 12: 213-221.
25. Gocmen C et al. Effect of vitamin E and sodium selenate on neurogenic and endothelial relaxation of corpus cavernosum in the diabetic mouse. Eur J Pharmac 2000; 398: 93-98.
26. Jeremy JY et al. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cylic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 1997; 79: 958-963.
27. Kim NN et al. Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor. Life Sci 2001; 69(19): 2249-2256.
28. Moreland RP, Goldestein I, Traish A. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells. Life Sci 1998; 62(20): PL 309-318.
29. Kim NN et al. Cross-regulation of intracellular cGMP and camp in cultured human corpus cavernosum smooth muscle cells. Moll Cell Biol Res Commun 2000; 4(1): 10-14.
30. Sato Y, Zhao W, Christ G. Central modulation of the NO/cGMP pathway effect the MPOA-induced intracavernous pressure response. Am J Physiol 2001; 281: R269-R278.